Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Motorola Solutions Inc (MSI) Price & Performance

Eli Lilly And CoTrade
Motorola Solutions IncTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Motorola Solutions Inc — how do they compare? Eli Lilly And Co trades at $1,206.31 (market cap $1.08T), while Motorola Solutions Inc trades at $465.07 (market cap $77.26B). The key difference: Eli Lilly And Co is far larger — about 14× Motorola Solutions Inc's market cap, and Motorola Solutions Inc pays the higher dividend (1.04%). Which is the better fit depends on your goals.

LLYMSI
Market Cap
$1.08T$77.26B
Sector
HealthTechnology
52-Week High
$1.24K$490.30
52-Week Low
$639.43$363.83
Enterprise Value
$1.13T$86.17B
Dividend Yield
0.57%1.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.

Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.

Motorola Solutions Inc

Motorola Solutions (MSI) trades at $461.98, down 1.19% today but has demonstrated strong momentum with three consecutive quarterly earnings beats and a 23.5% gain over three months. The company reported record Q2 2026 results with 13% revenue growth and raised full-year guidance, supported by a record $15.6 billion backlog. Technical indicators show a bullish trend with the stock near its pivot point of $463, while valuation metrics remain elevated with a P/E of 36.79.

The outlook remains positive given strong demand in public safety communications and software services, with analyst consensus pointing to 15% upside to the $533.80 price target. Key risks include execution challenges to meet elevated expectations and the premium valuation requiring sustained high growth. The combination of operational strength and bullish sentiment supports a constructive view for investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY

About Motorola Solutions Inc

Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.

Read more on MSI